Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent development in antithrombotic therapy.

J Fareed1

  • 1Hemostasis and Thrombosis Research Laboratory, Loyola University Medical Center, Maywood, Illinois.

Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional and Systemic Prothrombotic Biomarkers in Varicose Vein Patients and Healthy Controls.

Journal of vascular surgery. Venous and lymphatic disorders·2016
Same author

Blood Sampled Directly from Varicose Veins Reveals Activation of Inflammatory Processes.

Journal of vascular surgery. Venous and lymphatic disorders·2016
Same author

Do blood constituents in varicose veins differ from the systemic blood constituents?

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015
Same author

Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.

International angiology : a journal of the International Union of Angiology·2014
Same author

Pharmacological profile of sulodexide.

International angiology : a journal of the International Union of Angiology·2014
Same author

Medical management of patients with peripheral arterial disease.

International angiology : a journal of the International Union of Angiology·2014
Same journal

[Recommendations for a medical-meteorologic prognosis for hemophilia].

Folia haematologica (Leipzig, Germany : 1928)·1990
Same journal

[Malondialdehyde formation by platelets of hemophiliacs].

Folia haematologica (Leipzig, Germany : 1928)·1990
Same journal

Genomic carrier detection and prenatal diagnosis of haemophilia A in families at risk using the polymerase chain reaction (PCR).

Folia haematologica (Leipzig, Germany : 1928)·1990
Same journal

Diagnosis of carriers of haemophilia A by RFLP analysis: Austrian results.

Folia haematologica (Leipzig, Germany : 1928)·1990
Same journal

Genomic diagnosis of haemophilia A and B in the German Democratic Republic.

Folia haematologica (Leipzig, Germany : 1928)·1990
Same journal

[Paradoxical bleeding as a complication of the treatment of hemophilia with factor VIII and factor IX preparations].

Folia haematologica (Leipzig, Germany : 1928)·1990
See all related articles

Newer antithrombotic therapies are emerging, driven by a deeper understanding of molecular thrombosis and advancements in biotechnology. These innovations offer improved strategies for preventing blood clots.

Area of Science:

  • Pharmacology
  • Biotechnology
  • Hematology

Background:

  • Thrombotic processes are complex molecular events.
  • Traditional antithrombotic therapies have limitations.

Purpose of the Study:

  • To review novel concepts in antithrombotic therapy.
  • To highlight the impact of molecular understanding and technological advances.

Main Methods:

  • Literature review of recent advancements.
  • Analysis of molecular mechanisms in thrombosis.
  • Evaluation of biotechnological and separation techniques.

Main Results:

  • Introduction of new antithrombotic agents.
  • Improved understanding of thrombotic pathways.

Related Experiment Videos

  • Enhanced diagnostic and therapeutic tools.

    • Conclusions:

    • Molecular insights and technological progress are revolutionizing antithrombotic strategies.
    • Future antithrombotic therapy will be more targeted and effective.